| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective
|
Fenton, Wayne S.
|
|
2003
|
169 |
3-4 |
p. 365-366
|
artikel
|
| 2 |
Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study
|
Harvey, Philip D.
|
|
2003
|
169 |
3-4 |
p. 404-411
|
artikel
|
| 3 |
Cognition in schizophrenia: from basic science to clinical treatment
|
Harvey, Philip D.
|
|
2003
|
169 |
3-4 |
p. 213-214
|
artikel
|
| 4 |
Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia
|
Sharma, Tonmoy
|
|
2003
|
169 |
3-4 |
p. 398-403
|
artikel
|
| 5 |
Cognitive rehabilitation in schizophrenia: a quantitative analysis of controlled studies
|
Krabbendam, Lydia
|
|
2003
|
169 |
3-4 |
p. 376-382
|
artikel
|
| 6 |
Differential effects of iloperidone, clozapine, and haloperidol on working memory of rats in the delayed non-matching-to-position paradigm
|
Gemperle, Angela Y.
|
|
2003
|
169 |
3-4 |
p. 354-364
|
artikel
|
| 7 |
DMXB, an α7 nicotinic agonist, normalizes auditory gating in isolation-reared rats
|
O'Neill, Heidi C.
|
|
2003
|
169 |
3-4 |
p. 332-339
|
artikel
|
| 8 |
Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm
|
Swerdlow, Neal R.
|
|
2003
|
169 |
3-4 |
p. 314-320
|
artikel
|
| 9 |
Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and α1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats
|
Abekawa, T.
|
|
2003
|
169 |
3-4 |
p. 247-256
|
artikel
|
| 10 |
Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning
|
McDonald, L. M.
|
|
2003
|
169 |
3-4 |
p. 321-331
|
artikel
|
| 11 |
Lamotrigine prevents ketamine but not amphetamine-induced deficits in prepulse inhibition in mice
|
Brody, Suzanne A.
|
|
2003
|
169 |
3-4 |
p. 240-246
|
artikel
|
| 12 |
Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia
|
Zuckerman, L.
|
|
2003
|
169 |
3-4 |
p. 298-307
|
artikel
|
| 13 |
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development
|
Krystal, John H.
|
|
2003
|
169 |
3-4 |
p. 215-233
|
artikel
|
| 14 |
Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation
|
Zuckerman, Lee
|
|
2003
|
169 |
3-4 |
p. 308-313
|
artikel
|
| 15 |
Prepulse inhibition during withdrawal from an escalating dosage schedule of amphetamine
|
Russig, Holger
|
|
2003
|
169 |
3-4 |
p. 340-353
|
artikel
|
| 16 |
Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol
|
Purdon, Scot E.
|
|
2003
|
169 |
3-4 |
p. 390-397
|
artikel
|
| 17 |
Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys
|
Linn, Gary S.
|
|
2003
|
169 |
3-4 |
p. 234-239
|
artikel
|
| 18 |
Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies
|
Gabrovska-Johnson, V. S.
|
|
2003
|
169 |
3-4 |
p. 367-375
|
artikel
|
| 19 |
Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications
|
Keefe, Richard S. E.
|
|
2003
|
169 |
3-4 |
p. 383-389
|
artikel
|
| 20 |
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment
|
Weiner, Ina
|
|
2003
|
169 |
3-4 |
p. 257-297
|
artikel
|
Tijdschrift beschrijving